Dear shareholders and prospective shareholders,
In April, we hosted our first quarter, 2013 conference call. During our prepared remarks, we communicated a number of key points to help the Street better understand our business.
We spoke about the fact that a high priority for us moving forward is to continue to grow our top-line revenue. CRH’s revenue for the three months ended March 31, 2013, was $1,836,000 compared to $1,692,000 for the three months ended March 31, 2012, representing a 9 per cent increase.
Our focus is to keep that growth trajectory trending upwards. One of the initiatives we launched to support our revenue growth is our Clinical Support Specialist Program.
We solidified the program recently by directly employing the clinical support specialists who were previously contracted through the sales organization that we launched the initiative with.
Our four field reps continue to work to increase the adoption of the CRH O’Regan System within practices already trained by the Company, and to introduce the technology to practices not yet trained.
During the conference call, we also referenced our growing cash and cash equivalent reserves, which increased about 10 per cent over the fourth quarter of 2012, to $4,966,000.
Sharing the CRH story with the Street
We are looking forward to sharing the CRH Medical story in May at the second annual Bloom Burton & Co. Healthcare Investor Conference. For readers not familiar with the name, Bloom Burton is one of the premier healthcare investment banks in Canada. We attended their inaugural conference last year in Toronto and met with a number of high quality institutional investors. We look forward to doing the same again a few weeks from now.
We intend to follow up the conference with a day of marketing in Toronto and then a day in Montreal.
Earlier today, during a segment on BNN, Pender Growth Fund’s Chief Investment Officer David Barr referenced CRH Medical as one of his top small cap picks. To view the clip, please click the link below. Mr. Barr’s comments on CRH appear at approximately the five minute mark of the segment.
Raising awareness within the GI community
We attended the SAGES 2013 Annual Meeting in Baltimore on April 17-20. SAGES is an acronym for Society of American Gastrointestinal and Endoscopic Surgeons; the conference showcased innovative technology in the fields of general, gastrointestinal, endoscopic, robotic, and minimally invasive surgery.
For CRH Medical, the conference was an opportunity to generate several qualified customer leads, and to connect with a new, and very specialized group of physicians.
Also in April, the American Society for Gastrointestinal Endoscopy (ASGE) invited CRH Medical to participate in a course it put on entitled “GI Endoscopy for the Established Clinician”. The ASGE hosted the course at its new training facility in Oak Brook, Illinois. The ASGE selected the CRH O’Regan System as the hemorrhoid treatment technology of choice for the course. The O’Regan System was the focus of one of nine training stations where GIs had a hands-on opportunity to learn more about our technology. One of our trained physicians, Dr. David Greenwald, GI Fellowship Director at Montefiore Medical Center in Bronx, NY, presented the procedure and technology.
Toward the end of April, we went live with our new look for our corporate website. Readers can link to the website here: www.crhmedcorp.com
The site primarily features a new logo and colours. Our physician site (www.crhmedicalproducts.com), which was also revamped, features, among other upgrades, samples of our redesigned patient education and marketing materials.
We look forward to sharing the May edition of the CRH Investor Bulletin with you, and as always, we appreciate your interest and support.
Media and Investor Relations
416.815.0700 x 225